Table 2.
Baseline laboratory findings of survivors and deceased patients with serial changes of inflammatory parameters
| All patients (n = 68) | Survivors (n = 54) | Deceased patients (n = 14) | |
|---|---|---|---|
| White blood cell count, × 10^9/L | 6.5 (4.5–9.3) | 5.6 (4.3–9.3) | 7.2 (6.0–11.1) |
| Neutrophil count, × 10^9/L | 4.9 (3.1–7.8) | 4.2 (2.7–7.2) | 6.5 (5.0–9.6) |
| Lymphocyte count, × 10^9/L | 0.8 (0.7–1.1) | 0.9 (0.7–1.1) | 0.7 (0.5–0.9)* |
| Hemoglobin, g/L | 130.5 (117.5–141.8) | 125.0 (116.0–141.3) | 138.5 (135.3–145.8)* |
| Platelet count, × 10^9/L | 229.5 (168.8–293.3) | 236.5 (166.0–299.3) | 223.5 (193.5–260.3) |
| Albumin, g/L | 32.0 (29.2–34.0) | 32.3 (29.3–34.3) | 31.2 (28.5–33.7) |
| Blood bicarbonate ions, mmol/L | 23.6 (22.1–24.8) | 23.8 (22.4–24.8) | 22.3 (19.8–24.4) |
| Blood urea nitrogen, mmol/L | 4.9 (3.6–7.1) | 4.6 (3.6–6.4) | 7.7 (5.7–10.2)* |
| Blood creatinine, μmol/L | 71.0 (61.5–87.0) | 70.5 (59.5–85.0) | 78.5 (62.5–96.0) |
| hsCRP/lymphocyte, × 10^9 mg | 94.4 (45.9–184.1) | 86.5 (38.5–144.8) | 140.4 (79.4–330.6)* |
Data are expressed as median (IQR) or n (%). *P < 0.05 compared with the survivors